Production (Stage)
Senti Biosciences, Inc.
SNTI
$3.11
-$0.10-3.12%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 14.98% | 25.71% | -0.49% | 21.19% | 1.04% |
| Total Depreciation and Amortization | -3.06% | -1.01% | 10.00% | 39.49% | 42.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.06% | -82.95% | 147.39% | -96.59% | -45.36% |
| Change in Net Operating Assets | -72.24% | -2.29% | 217.49% | 15.42% | -43.86% |
| Cash from Operations | 8.39% | 20.99% | 35.75% | 13.60% | -16.12% |
| Capital Expenditure | 99.80% | 99.78% | 99.91% | 94.30% | 86.31% |
| Sale of Property, Plant, and Equipment | -42.86% | -42.86% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | 206.60% | 203.27% |
| Cash from Investing | -99.88% | -99.89% | 100.76% | 138.96% | 147.05% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 72.94% | 25.81% | -108.57% |
| Issuance of Common Stock | 5,430.89% | 5,430.89% | -50.38% | -51.22% | -29.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6,449.88% | 6,797.30% | 172.61% | -16.33% | -99.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 229.73% | 157.42% | 56.10% | 79.91% | -18.48% |